Inventiva S.A. Board of Directors

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH) and other diseases. Its lead product candidate is Lanifibranor, which is in Phase III clinical trial to treat NASH. The company also develops Odiparcil for the treatment of patients with mucopolysaccharidoses type VI. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company was founded in 2011 and is headquartered in Daix, France.

Mr. Frederic Cren

Mr. Frederic Cren

Co-Founder, CEO & Chairman

Dr. Pierre Broqua Ph.D.

Dr. Pierre Broqua Ph.D.

Co-Founder, Chief Scientific Officer, Deputy CEO & Director

Ms. Pascaline Clerc Ph.D.

Ms. Pascaline Clerc Ph.D.

Executive Vice President of Strategy & Corporate Affairs

Dr. Michael Cooreman

Dr. Michael Cooreman

Chief Medical Officer

Ms. Nathalie Harroy

Ms. Nathalie Harroy

Head of Human Resources

Dr. Kristina Meyer Ph.D.

Dr. Kristina Meyer Ph.D.

Executive VP and Business Development & Alliance Management

Leaving Board of Directors Review Your about to visit the following url Invalid URL

Loading...
Comments


Comment created.